<SEC-DOCUMENT>0001104659-20-122483-index.html : 20201106 <SEC-HEADER>0001104659-20-122483.hdr.sgml : 20201106 <ACCEPTANCE-DATETIME>20201106160209 ACCESSION NUMBER: 0001104659-20-122483 CONFORMED SUBMISSION TYPE: S-3ASR PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20201106 DATE AS OF CHANGE: 20201106 EFFECTIVENESS DATE: 20201106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3ASR SEC ACT: 1933 Act SEC FILE NUMBER: 333-249917 FILM NUMBER: 201294350 BUSINESS ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 BUSINESS PHONE: 908-200-7500 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>S-3ASR <SEQUENCE>1 <FILENAME>tm2034702-1_s3asr.htm <DESCRIPTION>S-3ASR <TEXT> Document 1 - file: tm2034702-1_s3asr.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>tm2034702-exh5_1.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: tm2034702-exh5_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>tm2034702-exh23_1.htm <DESCRIPTION>EX-23.1 <TEXT> Document 3 - file: tm2034702-exh23_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>lg_cantor-4c.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: lg_cantor-4c.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>lg_celldextherapeutics-4c.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: lg_celldextherapeutics-4c.jpg
</DOCUMENT> </SEC-DOCUMENT>